Dynamics of Nucleocapsid Antigen Serum Levels and Other Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients - a Pilot Study

Status: Recruiting
Study Type: Observational
SUMMARY

Patients requiring admission to the hospital due to a moderate and severe COVID-19 infection may differ in their ability to respond to viral infection and to eliminate viral load. Several comorbidities and interventions like antivirotic or antiinflammatory treatment may also modify expected patients response and decrease of viral load. In this observational study, evolution of selected inflammatory markers, indicators of severity of infection and patient characteristics will be followed and recorded in hospitalized patients with COVID-19.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:

• SARS CoV2 positive test within last 14 day

• bilateral infiltrates on chest X.ray or CT

• need for oxygen to keep pulse oximetry saturation above 92% or other respiratory support measures (HFNO, non-invasive ventilation or invasive ventilation)

Contact Information
Primary
Pavel Dostál, MD, PhD
pavel.dostal@fnhk.cz
+420602455632
Backup
Vladimir Koblizek, MD, Ph.D.
vladimir.koblizek@fnhk.cz
+420723448641
Time Frame
Start Date: 2021-04-01
Estimated Completion Date: 2026-08
Participants
Target number of participants: 30
Related Therapeutic Areas
Sponsors
Leads: University Hospital Hradec Kralove

This content was sourced from clinicaltrials.gov